Latisse is classed by the FDA as pregnancy class “C.” Class “C” means that animal studies have shown there might be some negative impact of the medication on pregnancy. In the case of Latisse, animal studies showed that at the approximate equivalent of 41 times the human dose, mothers saw a decreased gestation period and fetal weight, while there was an increase in dead fetuses, fetal resorption, fetal mortality, and pup mortality. Whether this means that women will experience negative impacts as a result is unknown, but in general this does not seem like a good risk to take except in special circumstances.
Animal studies have also shown that Latisse can be passed through breast milk in animals. This also means you should probably not resume using Latisse until after you have finished nursing your baby.
Click here see more plastic surgery procedures and treatments performed by Board Certified Plastic Surgeon, Dr. Eugene Kim on patients in Beverly Hills, Los Angeles, Hollywood, Santa Monica and surrounding areas or call 310-271-6996 to schedule a consultation.
